Specificity and utility of SubB2M, a new N-glycolylneuraminic acid lectin

Highlights: • SubB2M showed improved specificity and recognition for Neu5Gc containing glycans in a Neu5Ac/Neu5Gc glycan array and by surface plasmon resonance. • Far-western blot analysis showed that SubB2M preferentially binds to serum glycoproteins from bovine over human. • SubB2M detected Neu5Gc-glycoproteins spiked into normal human serum with greater sensitivity than SubB and anti-Neu5Gc IgY. • SubB2M will be a useful tool for the testing of serum and other bodily fluids for cancer diagnosis and prognosis. The B subunit of the subtilase cytotoxin (SubB) recognises N-glycolylneuraminic acid (Neu5Gc) containing glycans, the most prominent form of aberrant glycosylation in human cancers. We have previously engineered SubB by construction of a SubB_{ΔS106/ΔT107} mutant (SubB2M) for greater specificity and enhanced recognition of Neu5Gc containing glycans. In this study, we further explore the utility of SubB2M as a Neu5Gc lectin by showing its improved specificity and recognition for Neu5Gc containing glycans over the wild-type SubB protein and an anti-Neu5Gc IgY antibody in a N-acetylneuraminic acid (Neu5Ac)/Neu5Gc glycan array and by surface plasmon resonance. Far-western blot analysis showed that SubB2M preferentially binds to bovine serum glycoproteins over human serum glycoproteins. SubB2M was also able to detect Neu5Gc containing bovine glycoproteins spiked into normal human serum with greater sensitivity than the wild-type SubB and the anti-Neu5Gc IgY antibody. These results suggest that SubB2M will be a useful tool for the testing of serum and other bodily fluids for cancer diagnosis and prognosis.